| Lastest Insider Transactions Of Inhibrx Biosciences, Inc. ( INBX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Directior | 2026-09-08 | Buy | 5,000 | 113.52 | 567,580 | 2026-09-08 17:23:30 |
| INBX | Inhibrx Biosciences, Inc. | FORSYTH DOUGLAS | Directior | 2026-09-08 | Buy | 2,500 | 114.65 | 286,617 | 2026-09-08 16:26:03 |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | 2026-09-08 | Buy | 25,000 | 105.82 | 2,645,399 | 2026-09-08 16:04:45 |
| INBX | Inhibrx Biosciences, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | 2025-10-07 | Sell | 350,000 | 32.25 | 11,287,500 | 2025-10-09 16:41:40 |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Directior | 2024-11-19 | Buy | 107,186 | 14.21 | 1,523,620 | 2024-11-22 16:03:55 |
| INBX | Inhibrx Biosciences, Inc. | Lappe Mark | Chief Executive Officer | 2024-09-12 | Buy | 40,000 | 15.73 | 629,117 | 2024-09-16 17:12:34 |
| INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Directior | 2024-09-10 | Buy | 6,636 | 15.07 | 99,992 | 2024-09-12 17:14:23 |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Directior | 2024-06-05 | Buy | 57,549 | 17.32 | 997,024 | 2024-06-07 18:05:13 |
| INBX | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Directior | 2024-05-31 | Buy | 286,786 | 17.18 | 4,927,580 | 2024-06-04 17:27:32 |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | 2024-05-28 | Sell | 300,000 | 34.30 | 10,290,000 | 2024-05-30 18:21:58 |
| INBX | Inhibrx, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | 2023-08-28 | Buy | 511,627 | 19.35 | 9,899,982 | 2023-08-30 20:44:16 |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | 2023-03-01 | Sell | 40,000 | 24.21 | 968,231 | 2023-03-02 16:17:17 |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | 2023-02-28 | Sell | 60 | 25.02 | 1,501 | 2023-03-01 16:41:37 |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | 2023-02-01 | Sell | 40,000 | 24.93 | 997,210 | 2023-02-02 19:26:57 |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | 2023-01-23 | Sell | 26,000 | 25.42 | 660,842 | 2023-01-24 18:46:02 |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Directior | 2023-01-23 | Sell | 9,500 | 25.26 | 239,999 | 2023-01-23 18:10:31 |
| INBX | Inhibrx, Inc. | Eckelman Brendan P. | Chief Scientific Officer | 2023-01-03 | Sell | 40,000 | 23.71 | 948,598 | 2023-01-04 17:53:36 |
| INBX | Inhibrx, Inc. | Kayyem Jon Faiz | Directior | 2022-12-21 | Sell | 9,500 | 27.02 | 256,679 | 2022-12-22 16:04:29 |
| INBX | Inhibrx, Inc. | Lappe Mark | Chief Executive Officer | 2022-12-19 | Sell | 26,000 | 25.56 | 664,443 | 2022-12-20 16:59:55 |
